Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03057743
What this trial is testing

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Who this might be right for
METASTATIC BREAST CANCER
Abramson Cancer Center at Penn Medicine 4
Testing effectiveness (Phase 2)WithdrawnNCT04265274
What this trial is testing

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer
National Cancer Institute, Slovakia
Testing effectiveness (Phase 2)Study completedNCT00258960
What this trial is testing

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 49
Not applicableLooking for participantsNCT06991946
What this trial is testing

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 300
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Not applicableStudy completedNCT03998618
What this trial is testing

Telephone Support for Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Indiana University 250
Not applicableStudy completedNCT07223476
What this trial is testing

Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,926
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Looking for participantsNCT06222879
What this trial is testing

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT00082810
What this trial is testing

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 33
Large-scale testing (Phase 3)UnknownNCT00025688
What this trial is testing

Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Theradex
Not applicableEnded earlyNCT00595296
What this trial is testing

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Who this might be right for
Breast Cancer
Janssen Diagnostics, LLC 461
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387
What this trial is testing

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT02687490
What this trial is testing

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 81
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Next Page